U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06968754) titled 'The Impact of Pharmaceutical Care on the Infection Control Measures Among Hemodialytic Patients' on May 05.
Brief Summary: The study aims to assess the effectiveness of pharmaceutical care in reducing infection rates among hemodialysis patients with central venous (CV) lines. It will evaluate the role of clinical pharmacists in optimizing infection management and antimicrobial use. Additionally, the study will examine the impact of pharmacist-led education on patient adherence to infection prevention and medication regimens. The role of pharmacists in reducing catheter-related bloodstream infections (CRBSIs) and other dialysis-relate...